INSIGHTS ON DRUG DEVELOPMENT
-
Amorphous Solids: Implications For Solubility And Stability
Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.
-
Revolutionizing Drug Discovery From "Undruggables" To AI
Explore four current trends in drug discovery, how each trend addresses some of the most crucial challenges in drug discovery, and the obstacles to their widespread adoption.
-
Improving In Vitro Cancer Modeling
Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.
-
Organ-Chips For Drug Development
Delve into how Organ-on-Chip technology significantly enhances drug development processes and improves the accuracy of clinical translation, leading to more effective and reliable therapeutic outcomes.
-
Enhance Cell Line Development With Rapid Whole-Well Imaging11/7/2025
Whole-well imaging streamlines clone selection by enabling rapid, automated analysis of single-cell growth and morphology, which reduces manual effort and improves reproducibility.
-
Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives3/11/2026
By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.
-
Recombinant Protein Process Development And Scale-Up6/26/2025
Discover a resin for recombinant protein purification with a standardized protocol that streamlines workflows from lab to production, which saves time and enhances efficiency across development stages.
-
AustinPx Site Tour5/2/2025
Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.
-
Why Manual QbD Leads To Delays, Errors, And Ongoing Frustrations10/24/2025
Manual QbD methods slow timelines and increase risk. Learn how intelligent, digital frameworks are helping CMC teams improve quality, accelerate submissions, and meet rising regulatory expectations.
DRUG DEVELOPMENT SOLUTIONS
-
Leica S9 I Greenough Stereo Microscope
Save up to 20% inspection and rework time*
Continuously improving production, keeping defect rates low, and fulfilling customer requests in order to stay competitive can be very challenging. Leica has developed the S9 stereo microscope series to help you cope with these challenges. With this generation of Greenough stereo microscopes operators will be able to reveal details faster as they spend less time having to adjust the microscope.
*compared to the standard industrial stereo microscope S6 from Leica
-
Titanium dioxide is extensively used in solid dosage forms as an opacifier and colorant. Due to regulatory developments and restrictions by authorities, formulators are increasingly interested in titanium dioxide-free solutions for both dietary supplements and medicinal products. Uniform colored and white coatings applied to tablets not only have an aesthetic function but also improve patient compliance.
-
Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards.
-
Cell DIVE Multiplex Imaging Solution
What if every scientist could map normal and diseased tissue by cell type, biomarker profile, and specific features?
Cell DIVE is a precise, open multiplexing solution that lets your research dictate the level of automation required, which antibodies to use, how to build your antibody panel, and more.
-
Enhance your research and obtain exceptional imaging and analysis with a configurable and upgradeable high-content screening system that captures high-definition images and robust data from 2D and 3D assays.